AVITA Medical (RCEL) Net Income towards Common Stockholders Growth (1y) (2019 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.60% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | AVITA Medical | 121.89 Mn | 103.71 Mn | 14.31 Mn | -0.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.39% |
| Sep 30, 2025 | 18.62% |
| Jun 30, 2025 | 35.56% |
| Mar 31, 2025 | 25.72% |
| Dec 31, 2024 | -130.77% |
| Sep 30, 2024 | -86.01% |
| Jun 30, 2024 | -48.24% |
| Mar 31, 2024 | -102.36% |
| Dec 31, 2023 | 785.60% |
| Sep 30, 2023 | -55.91% |
| Mar 31, 2023 | 2.57% |
| Sep 30, 2022 | 6.05% |
| Mar 31, 2022 | -57.80% |
| Sep 30, 2021 | 41.84% |
| Jun 30, 2021 | 63.47% |
| Mar 31, 2021 | 60.15% |
| Dec 31, 2020 | 60.65% |
| Sep 30, 2020 | -186.79% |
| Jun 30, 2020 | -69.48% |
| Mar 31, 2020 | -143.42% |
| Dec 31, 2019 | -128.76% |
| Sep 30, 2019 | 29.16% |
| Jun 30, 2019 | 47.82% |